Abstract
The (2-methoxyphenyl) piperazine (MPP) was selected as the functional group and conjugated to dithiocarbamate through different spacers. A series of new MPP derivatives (MPPnDTC, n = 2–6) were synthesized and radiolabelled with 99mTc-nitrido core or 99mTc-tricarboxyl core as potential 5-HT1A receptor imaging agents. All the six 99mTc-labelled complexes were lipophilic and neutral. Biodistribution results showed that those radiotracers had moderate initial brain and hippocampus uptake. There have no significant relation was observed between the biological properties of these tracers with the length of its carbon chain. The radioactivity concentrations of hippocampus of 99mTcN-MPP2DTC, 99mTcN-MPP3DTC, 99mTcN-MPP4DTC, 99mTcN-MPP5DTC, 99mTcN-MPP6DTC and 99mTc(CO)3-MPP3DTC at 2 min post-injection time (p.i.) were 0.43, 1.15, 0.99, 1.04, 1.13 and 0.83 %ID/g, respectively.
Similar content being viewed by others
References
Gross C, Zhuang XX, Stark K, Ramboz S, Oosting R, Kirby L, Santarelli L, Beck S, Hen R. Serotonin(1A) receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature, 2002, 416: 396–400
Parsey RV, Belanger MJ, Sullivan GM, Simpson NR, Stabin MG, Van Heertum R, Mann JJ. Biodistribution and radiation dosimetry of C-11-WAY100,635 in humans. J Nuclear Med, 2005, 46(4): 614–619
Pike VW, Halldin C, Wikstrom H, Marchais S, McCarron JA, Sandell J, Nowicki B, Swahn C-G, Osman S, Hume SP. Radioligands for the study of brain 5-HT1A receptors in vivo — Development of some new analogues of WAY. Nuclear Med Biology, 2000, 27(5): 449–455
Papagiannopoulou D, Pirmettis I, Tsoukalas C, Nikoladou L, Drossopoulou G, Dalla C, Pelecanou M, Papadopoulou-Daifotis Z, Papadopoulos M, Chiotellis E. Oxotechnetium (TcO)-Tc-99m[SN(R)S][S] complexes as potential 5-HT1A receptor imaging agents. Nuclear Medicine and Biology, 2002, 29(8): 825–32
Heimbold I, Drews A, Syhre R, Kretzschmar M, Pietzsch HJ, Johannsen B. A novel technetium-99m radioligand for the 5-HT1A receptor derived from desmethyl-WAY-100635 (DWAY). Eur J Nuclear Med, 2002, 29(1): 82–87
Heimbold I, Drews A, Kretzschmar M, Varnas K, Hall H, Halldin C, Syhre R, Kraus W, Pietzsch HJ, Seifert S. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT1A receptor and the alpha1-adrenergic receptor. Nuclear Med Biolog, 2002, 29(4): 375–387
Leon A, Rey A, Mallo L, Pirmettis I, Papadopoulos M, Leon E, Pagano M, Manta E, Incerti M, Raptopoulou C. Novel mixed ligand technetium complexes as 5-HT1A receptor imaging agents. Nuclear Med Biolog, 2002, 29(2): 217–226
Bolzati C, Mahmood A, Malago E, Uccelli L, Boschi A, Jones AG, Refosco F, Duatti A, Tisato F. The [Tc-99m(N)(PNP)]2+ metal fragment: A technetium-nitrido synthon for use with biologically active molecules the N-(2-methoxyphenyl)piperazyl-cysteine analogues as examples. Bioconjugate Chem, 2003, 14(6): 1231–1242
Fan WW, Lin Y, Zhang XZ, Pang Y, Ma C, Tang ZG, Zhang JB, Wang XB. Synthesis and biological evaluation of Tc-99m-HEDTA/HYNIC-MPP4 complex for 5-HT1A receptor imaging. Sci China Ser B: Chem, 2009, 52(5): 590–598
Wang F, Wang X, Yang S, Liu J, Zhang X. N-[3-[4-(2-Methoxyphenyl) piperaziny-1-yl]propyl]cyclam: Synthesized as a potential 5-HT1A receptor ligand and labelled with 99mTc-nitrido core. J Label Comp Radiopharmac, 2008, 51(10): 347–351
Mou T, Yang W, Peng C, Zhang X, Ma Y. [18F]-Labeled 2-methoxyphenylpiperazine derivative as a potential brain positron emission tomography imaging agent. Appl Radia Isotop, 2009, 67(11): 2013–2018
Zhang XZ, Zhou PW, Liu JJ, Huang Y, Lin Y, Chen YL, Gu T, Yang WJ, Wang XB. Preparation and biodistribution of Tc-99-tricarbonyl complex with 4-[(2-methoxyphenyl)piperazin-1-yl]-dithioformate as a potential 5-HT1A receptor imaging agent. Appli Radia Isotop, 2007, 65(3): 287–292
Zhang J, Ren J, Lin X, Wang X. Synthesis and biological evaluation of a novel 99mTc nitrido radiopharmaceutical with deoxyglucose dithiocarbamate, showing tumor uptake. Bioorg Med Chem Lett, 2009, 19(10): 2752–2754
Zhang J, Lin Y, Sheng X, Wang X. Synthesis of a novel 99mTc nitrido radiopharmaceutical with isopropyl xanthate, showing brain uptake. Appl Radiat Isot, 2009, 67(1): 79–82
Alberto R, Schibli R, Schubiger AP, Abram U, Pietzsch HJ, Johannsen B. First application of fac-[Tc-99m(OH2)3(CO)3]+ in bioorganometallic chemistry: Design, structure, and in vitro affinity of a 5-HT1A receptor ligand labeled with Tc-99m. J Am Chem Soc, 1999, 121(25): 6076–6077
Alberto R, Schibli R, Egli A, Schubiger AP, Abram U, Kaden TA. A novel organometallic aqua complex of technetium for the labeling of biomolecules: Synthesis of [Tc-99m(OH2)3(CO)3]+ from [99mTcO4]− in aqueous solution and its reaction with a bifunctional ligand. J Am Chem Soc, 1998, 120(31): 7987–7988
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yang, W., Lin, Y., Zhang, X. et al. Synthesis of several MPP derivatives for 99mTc-labelling and evaluated as potential 5-HT1A receptor imaging agents. Sci. China Chem. 54, 1148–1154 (2011). https://doi.org/10.1007/s11426-011-4271-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11426-011-4271-5